Biallelic variants in TARS2 are linked to mitochondrial myopathy, SNHL, and epilepsy, all of which are indicative of the profound impact that mitochondrial dysfunction can have on both auditory and neural tissues [23, 24]. This evidence concerns the gene TARS2 and sensorineural hearing loss disorder.